Helicobacter pylori - Can the mechanisms of pathogenesis guide us towards novel strategies for treatment and prevention?

Journal of Internal Medicine

Volumn 240, Issue 6, 1996, Pages 319-332

  Falk, Per ^a,b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adenocarcinoma; Helicobacter pylori; Infection; Inflammation; Pathogenesis

Indexed keywords

ANTIBIOTIC AGENT; BACTERIAL VACCINE; CLARITHROMYCIN; HISTAMINE H2 RECEPTOR ANTAGONIST; METRONIDAZOLE; PROTON PUMP INHIBITOR;

BACTERIAL COLONIZATION; BACTERIAL INFECTION; BACTERIAL VIRULENCE; GASTROINTESTINAL DISEASE; HELICOBACTER PYLORI; HUMAN; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SYMPTOMATOLOGY;

EID: 0030461851     PISSN: 09546820     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2796.1996.75881000.x     Document Type: Review

References (93)

1. Marshall BJ, Warren RJ. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulcerations. Lancet 1984; i: 1311-4.
2. Marshall BJ, Armstrong JA, McGechie DB, Glancy RJ. Attempt to fulfil Koch's postulates for pyloric Campylobacter. Med J Aust 1985; 142: 436-9.
3. Goodwin CS, Armstrong JA, Chilvers T, Peters M, Collins MD, Sly L, et al. Transfer of Campylobacter pylori and Campylobacter mustelae to Helicobacter gen. nov. as Helicobacter pylori comb. nov. and Helicobacter mustelae comb. nov., respectively. Int J Syst Bact 1989; 39: 397-405.
4. Cover TL, Blaser MJ. Helicobacter pylori infection, a paradigm for chronic mucosal inflammation: pathogenesis and implications for eradication and prevention. Adv Intern Med 1996; 42: 85-117.
5. Sartor RB. Microbial factors in Crohn's disease, ulcerative colitis, and experimental intestinal inflammation. In: Kirsner JB, Shorter RG, eds. Inflammatory Bowel Disease, 4th edn. Baltimore: Williams & Wilkins, 1995; 96-124.
6. Bry L, Falk PG, Midtvedt T, Gordon JI. A model of host-microbial interactions in an open mammalian ecosystem. Science 1996; 273; 1380-3.
7. Forman D, Webb P. Geographic distribution and association with cancer. In: Northfield TC, Mendall M, Coggin PM, eds. Helicobacter pylori Infection. London: Kluwer Academic, 1993; 11-20.
8. Graham DY, Malaty HM, Evans DG, Evans Jr. DJ, Klein PD, Adam E. Epidemiology of Helicobacter pylori in an asymptomatic population in the United States: effect of age, race, and socioeconomic status. Gastroenterology 1991; 100: 1495-1501.
9. Baskerville A, Newell DG. Naturally occurring chronic gastritis and C. pylori infection in the Rhesus monkey: a potential model for gastritis in man. Gut 1988; 29: 465-72.
10. Majmudar P, Shah SM, Phunjibhoy KR, Desai HG. Isolation of Helicobacter pylori from dental plaques in healthy volunteers. Ind J Gastroenterol 1990; 9: 271-2.
11. Thomas JE, Gibson GR, Darboe MK, Dale A, Weaver LT. Isolation of Helicobacter pylori from human faeces. Lancet 1992; 340: 1194-5.
12. Hultén T, Han SW, Engstrand L, Evans DG, Klein PD, Opekun AR, et al. Helicobacter pylori in the drinking water in Peru. Gastroenterology 1996; 110: 1031-5.
13. Tytgat GNJ, Rauws EAJ. Campylobacter pylori and its role in peptic ulcer disease. Gastroenterol Clin North Am 1990; 19: 183-96.
14. Wyatt JI, Rathbone BJ, Sobala GM, Shallcross T, Heatly RV, Axon T, Dixon MF. Gastric epithelium in the duodenum: its association with Helicobacter pylori and inflammation. J Clin Pathol 1990; 43: 981-6.
15. Soll AH. Gastric, duodenal, and stress ulcer. In: Sleisenger MH, Fordtran JS, eds. Gastrointestinal Disease, 5th edn. Philadelphia: WB Saunders, 1993; 580-679.
16. Nomura A, Stemmermann GN, Chyou PH, Perez-Perez GI, Blaser MJ. Helicobacter pylori infection and the risk for duodenal and gastric ulceration. Ann Intern Med 1994; 120: 977-81.
17. Graham DY, Lew GM, Klein PD, Evans DG, Evans Jr. DJ. Saeed ZA, Malaty HM. Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer: a randomized, controlled study. Ann Intern Med 1992; 116: 705-8.
18. a+ phenotype, and male sex as factors in predicting coexisting duodenal ulcer. Scand J Gastroenterol 1989; 24: 581-8.
19. The Eurogast Study Group. An international association between Helicobacter pylori infection and gastric cancer. Lancet 1993; 341: 1359-62.
20. International Agency for Research on Cancer monographs on the evaluation of carcinogenic risk to humans. Vol. 61. Schistosomes, liver flukes and Helicobacter pylori. Lyon, France: IARC, 1994: 177-240.
21. Correa P, Haenszel W, Cuello C, Zavalla D, Fontham E, Zarama G, et al. Gastric precancerous process in a high risk population: cross sectional studies. Cancer Res 1990; 50: 4731-6.
22. Sipponen P. Longterm consequences of gastroduodenal inflammation. Eur J Hepatol Gastroenterol 1992; 4 (Suppl. 2): S25-9.
23. Calmels S, Oshima H, Vincent P, Gounot AM, Bartsch H. Screening of microorganisms for nitrosation catalysis at pH 7 and kinetic studies on nitrosamine formation from secondary amines by E. coli strains. Carcinogenesis 1985; 6: 911-5.
24. Rass JR. Is intestinal metaplasia of gastric mucosa a precancerous lesion? In: Zhang YC, Kawai K, eds. Precancerous Conditions and Lesions of the Stomach. Berlin: Springer Verlag, 1993; 49-64.
25. Craanen ME, Dekker W, Blok P, Ferwerda J, Tytgat GNJ, Intestinal metaplasia and Helicobacter pylori: an endoscopic bioptic study of the gastric antrum. Gut 1992; 33: 16-20.
26. Falk P, Lorenz RG, Sharon N, Gordon JI. Moluccella laevis lectin, a marker for cellular differentiation programs in mouse gut epithelium. Am J Physiol 1995; 268: G553-63.
27. Recavarren-Acre S, Leon-Barúa R, Cok J, Berendson R, Gilman R, Ramírez-Ramos A, et al. Helicobacter pylori and progressive gastric pathology that predisposes to gastric cancer. Scand J Gastroenterol 1991; 26 (Suppl. 181): S51-7.
28. O'Connor HJ. Helicobacter pylori and gastric cancer: a review and hypothesis. Eur J Gastroenterol Hepatol 1992; 4: 103-9.
29. Sipponen P, Kosunen TU, Valle J, Riihelä M, Seppälä K. Helicobacter pylori infection and chronic gastritis in gastric cancer. J Clin Pathol 1992; 45: 319-23.
30. Wotherspoon AC, Doglioni C, Diss TC, Pan L, Moschini A, de Boni M, Isaacson PG. Regression of low grade B-cell gastric lymphoma of MALT type following eradication of Helicobacter pylori. Lancet 1993; 342: 575-7.
31. Parsonnet J, Hansen S, Rodriguez L, Gelb AB, Warnke RA, Jellum E, et al. Helicobacter pylori infection and gastric lymphoma. N Engl J Med 1994; 330: 1267-71.
32. Genta RM, Hammer HW, Graham DY. Gastric lymphoid follicles in Helicobacter pylori infection: frequency, distribution, and response to triple therapy. Hum Pathol 1993; 24: 577-83.
33. Holcombe C. Helicobacter pylori: the African enigma. Gut 1992; 33: 429-31.
34. Parsonnet J, Friedman GD, Vandersten DP, Chang Y, Vogelman JH, Orentreich RI, Sibley RK. Helicobacter pylori infection and the risk of gastric adenocarcinoma. N Engl J Med 1991; 325: 1127-31.
35. Michetti P, Wadström T, Kraehenbuhl JP, Lee A, Kreiss C, Blum AL. Frontiers in Helicobacter pylori research: pathogenesis, host response, vaccine development and new therapeutic approaches. Eur J Gastroenterol Hepatol 1996; 8: 717-22.
36. Mobley HLT, Haussinger RB. Microbial ureases: significance, regulation, and molecular characterization. Microb Rev 1989; 53: 85-108.
37. Eaton KA, Brooks CL, Morgan DR, Krakowka S. Essential role of urease in the pathogenesis of gastritis induced by Helicobacter pylori in gnotobiotic piglets. Infect Immun 1991; 59: 2470-5.
38. Grisham MB, Jefferson MM, Melton DF, Thomas EL, Chlorination of endogenous amines by isolated neutrophils. Ammonia-dependent bactericidal, cytotoxic, and cytolytic activities of the chloramines. J Biol Chem 1984; 259: 10404-13.
39. Hazell SL, Evans DJ, Graham DY. Helicobacter pylori catalase. J Gen Microbiol 1991; 137: 57-61.
40. Xiang Z, Censini S, Bayeli PF, Telford JL, Figura N, Rappnoli R, Covacci A. Analysis of expression of cagA and vacA virulence factors in 43 strains of Helicobacter pylori reveals that clinical isolates can be divided into two major types and that cagA is not necessary for expression of the vacuolating cytotoxin. Infect Immun 1995; 63: 94-8.
41. Blaser MJ, Perez-Perez GI, Kleanthous H, Cover TL, Peck RM, Chyuo PH, et al. Infection of Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res 1995; 55: 2111-5.
42. Nathanson C, Hoffman WD, Suffredini AF, Eichacker PQ, Danner RL. Selected treatment strategies for septic shock based on proposed mechanisms of pathogenesis. Ann Intern Med 1994; 120: 771-83.
43. Birkholz S, Knipp U, Nietzki C, Adamek RJ, Opferkuch W. Immunological activity of lipopolysaccharide of Helicobacter pylori on human peripheral mononuclear blood cells in comparison to lipopolysaccharides of other intestinal bacteria. FEMS Immunol Med Microbiol 1993; 6: 317-24.
44. Eaton KA, Morgan DR, Krakowka S. Motility as a factor in the colonization of gnotobiotic piglets by Helicobacter pylori. J Med Microbiol 1992; 37: 123-7.
45. Hazell SL, Mendz GL. The metabolism and enzymes of Helicobacter pylori: function and potential virulence effects. In: Goodwin CS, Worsley BW, eds. Helicobacter pylori, Biology and Clinical Practice, Boca Raton: CRC Press, 1993; 115-41.
46. Hultgren SJ, Abraham S, Caparon M, Falk P, St. Geme III JW, Normark S. Pilus and nonpilus bacterial adhesins: assembly and function in cell recognition. Cell 1993; 73: 887-901.
47. Clausen H, Hakomori Si. ABH and related histo-blood group antigens: immunochemical differences in carrier isotypes and their distribution. Vox Sang 1989; 56: 1-20.
48. Borén T, Falk P, Roth KA, Larson G, Normark S. Attachment of Helicobacter pylori to human gastric epithelium mediated by blood group antigens. Science 1993; 262: 1892-5.
49. Falk P, Roth KA, Borén T, Westblom TU, Gordon JI, Normark S. An in vitro adherence assay reveals that Helicobacter pylori exhibits cell lineage-specific tropism in the human gastric epithelium. Proc Natl Acad Sci USA 1993; 90: 2035-9.
50. Davin JC, Senterre J, Mahieu PR. The high lectin-binding capacity of human secretory IgA protects nonspecifically mucosae against environmental antigens. Biol Neonate 1991; 59: 121-5.
51. Strömqvist M, Falk P, Bergström S, Hansson L, Lönnerdal B, Normark S, Hernell O. Human milk κ-casein and inhibition of Helicobacter pylori adhesion to human gastric mucosa. J Ped Gastroenterol Nutr 1995; 21: 288-96.
52. Prieto PA, Muker P, Kelder B, Erney R, Gonzales D, Yun JS, et al. Remodelling of mice milk glycoconjugates by transgenic expression of a human glycosyltransferase. J Biol Chem 1995; 270: 29515-9.
53. Rotter JI. Peptic ulcer. In: Emery AEH, Rimoin DL, eds. The Principals and Practice of Medical Genetics. New York: Churchill Livingstone, 1983; 863.
54. Haas JF, Schottenfeld D. Epidemiology of gastric cancer. In: Lipkin M, Good R, eds. Gastrointestinal Tract Cancer. New York: Plenum Press, 1978; 175-206.
55. Appelmelk BJ, Simoons-Skit I, Negrini R, Moran AP, Aspinall GO, Forte JG et al. Potential role of molecular mimicry between Helicobacter pylori lipopolysaccharide and host Lewis blood group antigens in autoimmunity. Infect Immun 1996; 64: 2031-10.
56. x blood group antigens in human gastric adenocarcinoma and in normal gastric tissue. Cancer Res 1989; 49: 745-52.
57. Kojima N, Fenderson BA, Stroud MR, Goldberg RI, Habermann R, Toyokuni T, Hakomori Si. Further studies on cell adhesion based on Le(x)-Le(x) interaction, with new approaches: embryoglycan aggregation of F9 teratocarcinoma cells, and adhesion of various tumour cells based on Le(x) expression. Glycaconj J 1994; 11: 258-48.
58. Crabtree J. Mucosal immune responses to Helicobacter pylori. Eur J Gastroenterol Hepatol 1993; 5 (Suppl. 2): S30-2.
59. Tummuru MKR, Sharma SA, Blaser MJ. Helicobacter pylori picB, a homologue of the Bordotella pertussis toxin secretion protein, is required for induction of IL-8 in gastric epithelial cells. Molec Microbiol 1995; 18: 867-76.
60. Hatz RA, Meimarakis G, Bayerdörffer E, Stolte M, Kirchner T, Enders G. Characterization of lymphocytic infiltrates in Helicobacter pylori-associated gastritis. Scand J Gastroenterol 1996; 31: 222-8.
61. Shirley LR, Marsh WH. Campylobacter pylori gastritis in children with X-linked agammaglobulinemia (Abstract). J Allerg Clin Immunol 1989; 83: 287.
62. Karam SM, LeBlond CP. Dynamics of epithelial cells in the corpus of the mouse stomach V. Behaviour of the enteroendocrine and caveolated cells: general conclusions on cell kinetics in the oxyntic epithelium. Anat Rec 1993; 236: 333-40.
63. +ATPase activity. J Biol Chem 1985; 260: 13681-4.
64. Li Q, Karam SM, Gordon JI. Simian virus 40 T antigen-induced amplification of pre-parietal cells in transgenic mice. J Biol Chem 1995; 270: 15777-88.
65. Segal ED, Falkow S, Tompkins L. Helicobacter pylori attachment to gastric cells induces cytoskeletal rearrangements and tyrosine phosphorylation of host cell proteins. Proc Natl Acad Sci USA 1996; 93: 1259-64.
66. McGowan CC, Cover TL, Blaser MJ. Helicobacter pylori and gastric acid: biological and therapeutic implications. Gastroenterology 1996; 110: 926-38.
67. Khoshla SN, Jain N, Khoshla A. Gastric acid secretion in typhoid fever. Postgrad Med J 1993; 69: 121-3.
68. Mulholland G, Ardill JE, Fillmore D, Chittajallu RS, Fullarton GM, McColl KEL. Helicobacter pylori related hypergastrinemia is the result of a selective increase in gastrin 17. Gut 1993; 34: 757-61.
69. Queiroz DMM, Moura SB, Mendes EN, Rocha GA, Barbosa AJA, de Carvalho AST. Effect of Helicobacter pylori eradication on G-cell and D-cell density in children. Lancet 1994; 343: 1191-3.
70. Kuipers EJ, Lundell L, Klinkenberg-Knol EC, Havu N, Festen HPN, Liedman B, et al. Atrophic gastritis and Helicobacter pylori infection in patients with reflux esophagitis treated with omeprazole or fundoplication. N Engl J Med 1996; 334: 1018-22.
71. Fox JG, Lee A. Gastric Helicobacter infection in animals: natural and experimental infections. In: Goodwin CS, Worsley BW, eds. Helicobacter pylori. Biology and Clinical Practice. Boca Raton: CRC Press, 1993; 408-30.
72. b-containing glycoconjugates: a potential transgenic mouse model for Helicobacter pylori infection. Proc Natl Acad Sci USA 1995; 92: 1515-19.
73. Fox JG, Li X, Cahill RJ, Andrutis K, Rustgi AK, Odze R, Wang TC. Hypertrophic gastropathy in Helicobacter felis-infected wild-type C57Bl/6 mice and p53 hemizygous transgenic mice. Gastroenterology 1996; 110: 155-66.
74. Enno A, O'Rourke JL, Hewlett CR, Jack A, Dixon MF, Lee A. MALT-oma-like lesions in the murine gastric mucosa after long-term infection with Helicobacter felis. A mouse model for Helicobacter pylori induced gastric lymphoma. Am J Pathol 1995; 147: 217-23.
75. Marchetti M, Aricò B, Burroni D, Figura N, Rappuoli R, Ghiara P. Development of a mouse model of Helicobacter pylori infection that mimics human disease. Science 1995; 267: 1655-8.
76. Czinn SJ, Cai A, Nedrud JG. Protection of germ-free mice from infection by Helicobacter felis after active oral or passive IgA immunization. Vaccine 1993; 11: 637-42.
77. Michetti P, Corthésy-Theulaz I, Davin C, Haas R, Vaney AC, Heitz M, et al. Immunization of Balb/c mice against Helicobacter felis infection with Helicobacter pylori urease. Gastroenterology 1994; 107: 1002-11.
78. Sung JJY, Chung SCS, Ling TKW, Yung MY, Leung VKS, Ng EKW, et al. Antibacterial treatment of gastric ulcers associated with Helicobacter pylori. N Engl J Med 1995; 332: 139-42.
79. Hosking SW, Ling TKW, Chung SCS, Yung MY, Cheng AFB, Sung JJY, Li AKC. Duodenal ulcer healing by eradication of Helicobacter pylori without anti-acid treatment: randomized controlled trial. Lancet 1994; 343: 508-10.
80. Harris AW, Misiewicz JJ. Eradication of Helicobacter pylori. In: Calam J, ed. Bailliere's Clinical Gastroenterology. Vol. 9. Helicobacter pylori. London: Baillière Tindall, 1995; 583-613.
81. Suerbaum S, Leying H, Klemm K, Opferkuch W. Antibacterial activity of pantoprazole and omeprazole against Helicobacter pylori. Eur J Clin Microbiol Infect Dis 1991; 10: 92-3.
82. Melchers K, Weitzenegger T, Buhmann A, Steinhilber W, Sachs G, Schäfer KP. Cloning and membrane topology of a P type ATPase from Helicobacter pylori. J Biol Chem 1996; 271: 446-57.
83. Glupczynski Y, Goutier S, van der Borre C, Butzler JP, Burette A. Surveillance of Helicobacter pylori resistance to antimicrobial agents in Belgium from 1989 to 1994 (Abstract). Gut 1995; 37 (Suppl. 1): A56.
84. Neu HC. The crisis of antibiotic resistance. Science 1992; 257: 1064-73.
85. Araneo BA, Cebra JJ, Beuth J, Fuller R, Heidt PJ, Midtvedt T, et al. Problems and priorities for controlling opportunistic pathogens with new antimicrobial strategies: an overview of current literature. Zbl Bakt 1996; 283: 431-65.
86. Winberg J, Möllby R, Bergström J, Karlsson KA, Leonardsson I, Milh MA, et al. The Pap-G adhesin at the tip of P-fimbriae provides Escherichia coli with a competitive edge in experimental bladder infection of cynomolgus monkeys. J Exp Med 1995; 182: 1695-1702.
87. von Itzstein M, Wu WY, Kok GB, Pegg MS, Dyason JC, Jin B, et al. Rational design of potent sialidase-based inhibitors of influenza virus replication. Nature 1993; 363: 418-23.
88. Trail PA, Willner D, Lasch SJ, Henderson AJ, Hofstead S, Casazza AM, et al. Cure of xenografted human carcinomas by BR96-doxorubicin immunoconjugates. Science 1993; 261: 212-5.
89. Miller JF, Mekalanos JJ, Falkow S. Coordinate regulation and sensory transduction in the control of bacterial virulence. Science 1989; 243: 916-22.
90. 2-antagonist. Aliment Pharmacol Ther 1988; 2: 297-309.
91. Thomas JE, Austin S, Dale A, McClean P, Harding M, Coward WA, Weaver LT. Protection by human milk IgA against Helicobacter pylori infection in infancy. Lancet 1993; 342: 121.
92. Brandtzaeg P, Halstensen TS, Kett K. Immunopathology of inflammatory bowel disease. In: MacDermott RP, Stenson WF, eds. Inflammatory Bowel Disease. New York: Elsevier, 1992; 95-136.
93. Eaton K, Krakowka S. Chronic active gastritis due to Helicobarter pylori in immunized gnotobiotic piglets. Gastroenterology 1992; 103: 1580-6.